Previous studies have demonstrated that VHL loss-of-function mutations may induce angiogenesis and cell proliferation by evevating the expression of hypoxia-inducible factor (HIF) in ccRCC (44–47). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.